BioPharm America™: Interview with Christopher Viehbacher, Gurnet Point Capital

Christopher Viehbacher, managing partner at Gurnet Point Capital, and formerly the CEO of Sanofi, was interviewed by Joe Haas from “The Pink Sheet.” They discussed the business strategy of Gurnet Point Capital and the dealmaking environment at present in the biopharmaceutical industry. BioPharm America™ (www.ebdgroup.com/bpa) is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. “The Pink Sheet” provides in-depth coverage of the prescription pharmaceutical industry. Known as "The Bible" to the prescription pharmaceutical industry, this publication covers regulatory activities of the FDA, FTC and CMS; Congress; industry news, such as mergers and acquisition, new product introductions, and executive changes; and financial news, such as companies' sales/earning performance and stock activity. Its comprehensive coverage is vital for successful business development and commercialization strategies that drive profits. www.thepinksheet.com/.

• #news_politics
• #health
• #care
• #pharmaceuticals
• #medical
• #device
• #biotech
• #news
• #information
• #analysis
• #informa
• #pharmamedtechbi
• #business
• #intelligence